logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

LINGBAO GOLD (03330): The trading unit size will be changed from 2000 shares of H shares to 1000 shares of H shares.

date
18:59 12/02/2025
avatar
GMT Eight
Lingbao Gold (03330) announced that starting from 9:00 am on Thursday, March 6, 2025, it will be listed on the Hong Kong Stock Exchange...
LINGBAO GOLD (03330) announced that starting from 9:00 am on Thursday, March 6, 2025, the trading unit size for H shares traded on the Stock Exchange will be changed from 2000 shares to 1000 shares per hand.
Related Articles
HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.
US Stock
A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.
Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.
HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.
A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.
US Stock
Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.
RECOMMEND
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
icon
21/05/2026
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
icon
21/05/2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
icon
21/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.